Skip to main content
. 2022 Oct 6;9:912197. doi: 10.3389/fcvm.2022.912197

Table 4.

Risk ratios and 95% confidence intervals of the association of IR categories and its surrogate index with incident hypertension by age periods.

Incident hypertension Yong participants Elderly participants
(18age64 years old) (age65 years old)
Groups Model 1 Model 2 Model 1 Model 2
RR 95% CI P-value RR 95% CI P-value RR 95% CI P-value RR 95% CI P-value
HOMA-IR categories
Quartile 1 1 1 1 1
Quartile 2 1.12 0.88–1.44 0.355 1.17 0.91–1.50 0.234 0.91 0.51–1.63 0.747 0.88 0.48–1.63 0.688
Quartile 3 1.18 0.92–1.51 0.188 1.26 0.98–1.62 0.069 1.66 0.89–3.09 0.112 1.61 0.85–3.05 0.141
Quartile 4 1.56 1.56–1.99 < 0.001 1.67 1.31–2.14 < 0.001 1.17 0.67–2.04 0.583 1.13 0.64–2.01 0.677
HOMA-β categories
Quartile 1 1 1 1 1
Quartile 2 0.83 0.66–1.06 0.131 0.86 0.68–1.10 0.232 1.22 0.72–2.06 0.468 1.24 0.72–2.14 0.430
Quartile 3 0.79 0.62–1.00 0.047 0.81 0.64–1.04 0.094 0.83 0.83–1.52 0.540 0.76 0.40–1.45 0.406
Quartile 4 0.77 0.61–0.98 0.033 0.84 0.66–1.08 0.170 0.65 0.65–1.22 0.180 0.70 0.37–1.33 0.271
TyG categories
Quartile 1 1 1 1 1
Quartile 2 1.33 1.03–1.72 0.030 1.37 1.06–1.78 0.017 1.23 0.66–2.30 0.520 1.13 0.59–2.16 0.709
Quartile 3 1.81 1.41–2.31 < 0.001 1.28 1.39–2.28 < 0.001 1.31 0.68–2.52 0.426 1.49 0.74–2.98 0.263
Quartile 4 1.86 1.45–2.38 < 0.001 1.88 1.46–2.41 < 0.001 1.87 0.98–3.55 0.057 2.16 1.09–4.26 0.027
TG/HDL-C categories
Quartile 1 1 1 1 1
Quartile 2 1.17 0.91–1.51 0.217 1.19 0.92–1.53 0.188 0.88 0.49–1.57 0.659 0.92 0.51–1.67 0.790
Quartile 3 1.53 1.20–1.95 0.001 1.56 1.22–2.00 < 0.001 1.21 0.67–2.20 0.523 1.19 0.64–2.20 0.580
Quartile 4 1.44 1.13–1.85 0.004 1.49 1.16–1.91 0.002 1.14 0.62–2.08 0.673 1.25 1.25–2.39 0.503
VAI categories
Quartile 1 1 1 1 1
Quartile 2 1.38 1.07–1.77 0.013 1.41 1.10–1.82 0.008 0.77 0.41–1.44 0.416 0.81 0.43–1.53 0.514
Quartile 3 1.79 1.39–2.30 < 0.001 1.81 1.40–2.34 < 0.001 1.22 0.66–2.25 0.519 1.26 0.67–2.36 0.480
Quartile 4 1.64 1.64–2.10 < 0.001 1.67 1.30–2.15 < 0.001 1.07 1.07–2.04 0.838 1.09 0.56–2.11 0.810
LAP categories
Quartile 1 1 1 1 1
Quartile 2 1.56 1.20–2.03 0.001 1.54 1.18–2.01 0.002 2.24 1.19–4.19 0.012 2.21 1.17–4.18 0.014
Quartile 3 2.16 1.67–2.80 < 0.001 2.15 1.66–2.79 < 0.001 2.07 1.08–3.98 0.030 1.89 0.94–3.76 0.072
Quartile 4 2.34 1.82–3.00 < 0.001 2.29 1.77–2.95 < 0.001 2.01 1.02–3.97 0.045 2.08 1.03–4.20 0.040
TyG-BMI categories
Quartile 1 1 1 1 1
Quartile 2 1.48 1.13–1.95 0.005 1.52 1.15–2.01 0.003 1.90 1.07–3.38 0.030 1.99 1.09–3.63 0.026
Quartile 3 2.23 1.72–2.89 < 0.001 2.22 1.71–2.90 < 0.001 1.89 1.01–3.52 0.045 1.93 1.00–3.70 0.050
Quartile 4 2.96 2.29–3.82 < 0.001 2.93 2.26–3.80 < 0.001 2.83 1.52–5.27 0.001 2.80 1.45–5.39 0.002
TyG-WC categories
Quartile 1 1 1 1 1
Quartile 2 1.91 1.46–2.49 < 0.001 1.86 1.42–2.44 < 0.001 1.75 0.89–3.45 0.104 1.87– 0.90–3.57 0.098
Quartile 3 2.33 1.71–2.90 < 0.001 2.18 2.67–2.84 < 0.001 3.04 1.54–5.97 0.001 3.18 1.55–6.51 0.002
Quartile 4 3.23 2.49–4.19 < 0.001 3.09 2.38–4.02 < 0.001 2.33 1.21–4.47 0.011 2.49 1.26–4.91 0.009

Model 1: adjusted for sex in 2009.

Model 2: model 1+ smoke habits, alcohol consumption, community type, married status and education years.

HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β-cell function; TyG, triglyceride and glucose; VAI, visceral adiposity index; LAP, lipid accumulation product; BMI, body mass index.

Significant values were in bold.